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Abstract 
Introduction: Antimicrobial peptides as the body's defense strategy play an important role in 
resistance against infection of microorganism. These peptides are able to modulate the 
immune and inflammatory processes through the production of defensive molecules. 
Therefore, the modulatory effects of Brevinin-2R, an antimicrobial peptide extracted from the 
skin of the frog (Rana ridibunda), was evaluated in this study.  
Materials and methods: MTT assay was conducted for evaluating the cytotoxic effect of 
Brevinin-2R on human liver carcinoma cells (HepG2). Then, real-time PCR was used to 
assess the inﬂammatory properties of this peptide. 
Results: It was appeared that the Brevinin-2R has a low toxicity against HepG2 cancer cells 
and can reduce cell growth to 24%. Results of molecular analysis showed that Brevinin-2R 
increases the expression of IL-1b and IL-6 genes in cancer cells in a dose dependent manner. 
Conclusion: The results show that Brevinin-2R has a regulatory role in inflammation through 
targeting the genes involved in the process. 
Keywords: Brevinin-2R, Inﬂammation, Gene expression 
Introduction 
Antimicrobial peptides are parts of the 
endogenous immune to resist infection of 
microorganism (1). Widely, these peptides 
as endogenous antibiotics are able to 
inhibit the growth of pathogens (bacteria, 
fungi, viruses) (2, 3). So far, the peptides 
are purified from some invertebrates 
(insects, ticks) (4) and vertebrates 
(amphibians) (5, 6). Peptides are 
amphipathic molecules with hydrophobic 
and hydrophilic parts, they are positively 
charged due to the presence of some amino 
acids including histidine, lysine and 
arginine in their structure (7). The 
difference in amino acid composition, size 
and conformational structures leads to the 
diversity of the peptides (2). These 
peptides are involved in immunity and 
inflammation and can modulate the 
process through the production of 
defensive molecules (4). Various 
investigations have showed that these 
peptides have the effect of an increase in 
chemokine and cytokine's production (8, 
9). Angiogenesis and wound healing 
process inflammation is an immune 
process which is created as a result of the 
attack pathogens or tissue damage. 
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Macrophages play an important role in 
immune response and the release of nitric 
oxide (NO), TNF-α, interleukin-6, and -1β 
as a macrophage-released inﬂammatory 
mediators leads to an increase in defense 
capacity (10). Brevinin-2R is non-
hemolytic peptide and a member of the 
Brevinin-2 family with 25-amino acid 
(KLKNFAKGVAQSLLNKASCKLSGQC) 
that derived from secretions of frog skin 
(11). This peptide has shown antibacterial 
activity against gram positive and negative 
bacteria (12). Also, the peptide has shown 
cytotoxic effects on various cancer cell 
lines, including Jurkat, BJAB, HT29/219, 
SW742 cells and etc. (11).This study was 
conducted to evaluate the effects of the 
peptide on viability of HepG2 cells and 
also to evaluate its effect on the expression 
of genes involved in inflammation include 
IL-1b and IL-6 genes. 
Materials and methods 
Cell culture: HepG2 cancer cell line were 
purchased from NCBI (National Cell Bank 
of Iran) and cultured in DMEM medium 
supplemented with 10% Fetal Bovine 
Serum (FBS) (Gibco, USA), L-glutamine 
(Sigma, USA) and 1% antibiotic 
(penicillin/ streptomycin) and incubated at 
37 °C in a 5% CO2. 
Cell proliferation assay: The cytotoxic 
effect of Brevinin-2R on the HepG2 cells 
was evaluated using MTT assay. The 
HepG2 cells were seeded in 96-well plates 
at a concentration of 5 × 103 cells/well and 
incubated for 24 h. After completion of the 
incubation period the cells were exposed 
to various concentrations of peptide (10, 
20, 40 µg/ml) for 24, 48 and 72 h. After 
treatment period, the treatments were 
removed and MTT was added to each well 
and incubated for 4 hours at 37 ° C in the 
dark. After incubation, the MTT was 
removed and replaced with 100 µl DMSO 
and finally, the optical absorbance was 
measured at 570 nm with ELISA plate 
reader. All experiments were done in 
triplicate. 
Peptide Synthesis: The desired peptide 
(Brevinin-2R) was synthesized chemically 
using peptide synthesizer (Applied 
Biosystems Model 432A) and then 
purified using chromatography (C8 
column) method. The column was 
developed at a ﬂow speed of 2 ml/min by a 
linear gradient of 5–45 %acetonitrile for 
40 min containing 0.1 % TFA. Finally, the 
purity of Brevinin-2R was determined 
using an analytical column (4.6 × 250 mm,   
manufactured   by Macherey-Nagel GmbH 
& Co., Du¨ren, Germany) (13). 
Real time PCR: Real time PCR was 
conducted in order to detection of changes 
in inflammatory genes expression. Total 
cellular RNAs of treated (different 
concentration of Brevinin-2R) and 
untreated cells were extracted using the 
High Pure Isolation kit (Roche, Germany) 
according to the manufacturer’s 
guidelines. Then the RNA was used to 
determine the quantity and purity at 
wavelength 260 and 280 nm using Nano 
drop spectrometer (Thermo-scientiﬁc, 
Wilmington, USA). 2µ of extracted RNA 
was reverse transcribed to cDNA using 
thermo scientific kit according to 
manufactures protocol. Briefly, cDNA 
synthesis was done in the presence of 
Oligo (dT)18 Primer, 5X Reaction Buffer, 
RiboLock RNase Inhibitor, dNTP, 
RevertAid RT and water nuclease-free 
then transferred to the Biotech Thermal 
Cycler (London, England) incubated for 
60 min at 42°C and 70°C for 5 min. Next, 
in order to do the real time PCR, 2 µL of 
cDNA products was added to SYBER 
green, the appropriate forward and reverse 
primers and distilled water. Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was 
used as housekeeping gene. The sequences 
of used primers are showed in the table 1. 
Statistical analysis 
Data was assessed by SPSS software, One 
way ANOVA, LSD test with significance 
level of P<0.05. All results repeated three 
times and presented as mean ± SD.
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 Table 1. The sequences of primers used in the study. 
Gene Forward 5ꞌ to 3ꞌ Revers 5ꞌ to 3ꞌ 
GAPDH 5ꞌCAAGGTCATCCATGACAACTTTG3ꞌ 5ꞌGTCCACCACCCTGTTGCTGTAG3ꞌ 
IL-1b 5ꞌ GCTTATTACAGTGGCAATGA3ꞌ 5ꞌ GTGGTCGGAGATTCGTAG3ꞌ 
IL-6 5ꞌ TTCGGTCCAGTTGCCTTCTC 3ꞌ 5ꞌGAGGTGAGTGGCTGTCTGTG3ꞌ 
 
Results 
Effect of Brevinin-2R on cell 
proliferation of HepG2 cells: To assess 
the effect of Brevinin-2R on viability of 
HepG2 cells, treatment with different 
concentrations of peptide were performed. 
As shown in Figure 1, Brevinin-2R 
showed no significant toxic effects on cells 
and inhibited the cell growth about 5 to 
25% at concentrations of 10 to 40µg/ml.
 
 
 
 
Figure 1. The effect of different concentrations Brevinin-2R on viability of HepG2 cells at 24, 48 and 72 h 
compared with control. 
 
 
Regulatory effect of Brevinin-2R on 
expression levels inflammatory genes: 
Treatment of HepG2 cells with various 
concentration of B2R led to a significant 
increase in the expression of inflammatory 
genes in a dose dependent manner. As 
shown in Figure 2, the level of IL-1b gene 
expression is increased by increasing the 
concentration of peptide and there was 
observed a significant increase (P< 0.05) 
in gene expression at the concentrations of 
20 and 40µg/ml. The effect of B2R on IL-
6 expression in Hep2G cells is shown in 
Figure 2. As could be observed, with 
increasing the concentrations of peptide 
the expression level of IL-6 gene is also 
increased. 
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Figure 2. The effect of different concentrations of B2R on the expression level of IL-1b and IL-6 in HepG2 
cells, 48 h after treatment. Exposure to the peptide led to increased expression of IL-1b and IL-6 genes. 
Discussion  
So far, many studies have been carried out 
on cytotoxic effect of peptides extracted 
from various sources on cancer cells.  
LfcinB is an antimicrobial peptide that 
exerts its cytotoxic effects against of 
cancer cells through interact with 
negatively charged membranes of target 
cells (14). 
Gaegurin 6 (GGN6) is another type of 
peptide that has toxic effects against breast 
cancer lines.  In a study that conducted by 
Kima et al in 2003 was shown that 
changes in amino acids, removing or 
adding certain areas in GGN6 can lead to 
change its anticancer effects (15). For 
example, the removal of the amino 
terminal region significantly reduced its 
anti-cancer activity while there was no 
particular change in the activity of the 
peptide by removing the carboxyl terminal 
region. In general, it is recommended that 
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these peptides and derivatives can be 
considered as anti-cancer agents (15).  
In another study in 2012 examined the 
cytotoxic effects of peptides extracted 
from venom on cancer (Hela) and normal 
cell (LK) lines.  ICD-85 showed cytotoxic 
effects on tumor cells with IC50: 26.52 
µg/ml so that by increasing peptide 
concentration, increased the percentage of 
inhibition of Hela cells. In this study, was 
compared the cytotoxic effect of ICD-85 
on cancer with normal cells and the results 
showed that the minimum concentration of 
cytotoxic effect on normal cells (LK) 
3,500 fold less compared to the same 
levels in cancer cells (Hela) (16). 
In another study anti-cancer and cytotoxic 
effects of peptides Cecropin A and B were 
assessed on two cancer cell lines namely 
breast adenocarcinoma (MDA-MB-231) 
and human mesothelioma (M14K). The 
results showed that the toxicity of these 
peptides is dependent on the concentration 
and type of cancer cells and no association 
with the type of peptide. The M14K line 
cells had lower sensitivity to the action of 
Cecropins A and B than the MDA-MB-
231 line cells (17). 
The effects of peptides on the immune 
system and inflammation were 
investigated in various studies. Studies 
have shown that a wide range of anti-
microbial peptides caused the release of 
pro-inﬂammatory cytokines and 
chemokines (18-3). In this study, we 
evaluated the effects of Brevinin-2R as an 
antimicrobial peptide on the activity of the 
two cytokine namely IL1b and IL6 in 
HepG2 cells. For this purpose, cells were 
treated with different concentrations of 
peptide (10, 20, and 40) then were 
analyzed using real time pcr. IL1b and IL6 
showed an increase in expression 48 hours 
after treatment with B2R (Fig 2). Elssner 
and et al in 2004 investigated the effect of 
LL-37 on immune system and found that 
the peptide is able to increase the 
expression of IL-1b by monocytes (8) in 
another study that conducted by Yoshioka 
and et al in 2008 was shown that the 
expose of LAD2 cells with LL-37 peptide 
leads to the release of IL-1b from LAD2 
cells (19). 
rCRAMP is another form of the 
antibacterial peptide that exerts additive 
effects on the expression of IL-1b (as a 
pro-inﬂammatory cytokine) in glial cells 
(20).  
Investigation the effect of B2R peptide on 
lung cancer cells (A549) showed that this 
peptide can lead to increased expression of 
IL-1b (as a cytokine) and IL8 (as a 
chemokine). The results showed that the 
expression of these genes in A549 cell line 
is dependent on the concentration and time 
(13). Niyonsaba and et al in 2010 
investigated the effects of hBDs and LL-
37 (as antimicrobial peptides) and showed 
that both peptides are able to induce the 
release of certain factors such as IL-2, IL-
4, IL-6 (21). 
The results of the present study is similar 
to the above studies, approved the 
regulatory effects of antimicrobial peptides 
on expression of pro- inflammatory 
factors.
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